Real‑life Cost and cost‑effectiveness for Tiotropium 18 μg Od Monotherapy in Moderate and Severe COPD Patients: A 48‑month Survey. FE 2014, 15 (2), 39-44. https://doi.org/10.7175/fe.v15i2.924.